Beck Capital Management »

Vertex Pharmaceuticals Incorporated shares owned by Beck Capital Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Beck Capital Management from 13F filings

Historical chart of Beck Capital Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Beck Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Beck Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $789k 1.9k 418.01
2023-12-31 $767k 1.9k 406.89
2023-09-30 $658k 1.9k 347.74
2023-06-30 $658k 1.9k 351.91
2023-03-31 $661k 2.1k 315.07
2022-12-31 $644k 2.2k 288.78
2022-09-30 $660k 2.3k 289.35
2022-06-30 $631k 2.2k 281.95

More positions owned by Beck Capital Management

Nvidia Corporation Equity (NVDA)
Microsoft Corp Equity (MSFT)
Meta Platforms Inc Class A Equity (META)
Amazon.com Equity (AMZN)
Super Micro Computer Inc Com Usd0.001 Equity (SMCI)
Crowdstrike Hldgs Inc Cl A Equity (CRWD)
Blackstone Secd Lending Equity (BXSL)
Chipotle Mexican Grill Equity (CMG)
Invesco Exchange Traded Fd Tr Aerospace Defn Equity (PPA)
Eli Lilly &co Equity (LLY)
Spdr Ser Tr S&p Homebuild Equity (XHB)
Vertiv Holdings Co Com Cl A Equity (VRT)
J P Morgan Exchange Traded Fd Nasdaq Eqt Prem Equity (JEPQ)
Cameco Corp Com Npv Isin #ca13321l1085 Sedol #2166160 Equity (CCJ)
Invesco Exchange Traded Fd Tr S&p 100 Eql Wigh Equity (EQWL)

View all positions for Beck Capital Management

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
State Street Corporation
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Jennison Associates
Morgan Stanley
Massachusetts Financial Services
Bank of America Corporation
Henderson Group
T. Rowe Price Associates
Goldman Sachs Group
ClearBridge Advisors
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated